BiotechTube
Home/SynerFuse/Nameer R. Haider, MD, FAAPM&R, DABPM
NR

Nameer R. Haider, MD, FAAPM&R, DABPM

Chief Innovation Officer

SynerFuse

Therapeutic Areas

Chronic PainNeuroscience

SynerFuse Pipeline

DrugIndicationPhase
NeuroFuse System / e-TLIF ProcedureChronic low back and leg pain in patients undergoing lumbar spinal fusionFeasibility

Leadership Team at SynerFuse

JZ
Justin Zenanko, CPA, MDiv
Chief Executive Officer & Founder
RL
Rohan Lall, MD
Chief Medical Officer
MC
Michael C. Park, MD, PhD
Chief Technology Officer
View full SynerFuse profile